BL Pharmtech Corp. (KOSDAQ:065170)
South Korea
· Delayed Price · Currency is KRW 2,420.00
-65.00 (-2.62%)
At close: Apr 28, 2026
BL Pharmtech Revenue
In the year 2025, BL Pharmtech had annual revenue of 6.51B KRW, down -26.12%. BL Pharmtech had revenue of 810.47M in the quarter ending December 31, 2025, a decrease of -36.77%.
Revenue
6.51B
Revenue Growth
-26.12%
P/S Ratio
10.38
Revenue / Employee
542.14M
Employees
12
Market Cap
67.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.51B | -2.30B | -26.12% |
| Dec 31, 2024 | 8.81B | -15.72B | -64.10% |
| Dec 31, 2023 | 24.53B | 2.00B | 8.89% |
| Dec 31, 2022 | 22.52B | -61.92B | -73.33% |
| Dec 31, 2021 | 84.44B | 18.75B | 28.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jin Yang Pharmaceutical | 120.69B |
| Sinil Pharmaceutical | 80.56B |
| Kyung Nam Pharm | 56.18B |
| Optipharm.CO.,LTD | 22.34B |
| Hwail Pharmaceutical | 107.87B |
| Korea Arlico Pharm | 201.20B |
| GL Pharm Tech | 35.27B |
| RP Bio | 136.22B |